Calidi Biotherapeutics (CLDI)
NYSE MKT:CLDI
US Market
Holding CLDI?
Track your performance easily

Calidi Biotherapeutics (CLDI) Financial Statements

165 Followers

Calidi Biotherapeutics Financial Overview

Calidi Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-7.159; its P/E ratio is -0.29; Calidi Biotherapeutics is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.56M$ -7.07M$ -8.01M$ -1.69M$ -12.20M
EBITDA$ -5.16M$ -6.68M$ -7.65M$ -1.69M$ -11.53M
Net Income Common Stockholders$ -7.44M$ -7.22M$ -21.46M$ -2.02M$ -12.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 836.00K$ 1.14M$ 1.95M$ 10.15M$ 669.87K
Total Assets$ 6.43M$ 7.41M$ 10.02M$ 18.59M$ 44.01M
Total Debt$ 5.75M$ 8.50M$ 6.43M$ 7.41M$ 1.49M
Net Debt$ 4.92M$ 7.36M$ 4.48M$ -2.74M$ 820.13K
Total Liabilities$ 18.18M$ 21.98M$ 18.25M$ 19.68M$ 12.77M
Stockholders Equity$ -11.75M$ -14.57M$ -8.23M$ -1.09M$ -11.97M
Cash Flow-
Free Cash Flow$ -5.53M$ -3.81M$ -5.26M$ -22.89M$ -5.48M
Operating Cash Flow$ -5.53M$ -3.80M$ -5.19M$ -22.37M$ -5.17M
Investing Cash Flow-$ -5.00K$ -35.00K$ 277.31K$ -243.00K
Financing Cash Flow$ 5.20M$ 3.01M$ -2.96M$ 31.28M$ 6.58M
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History

Calidi Biotherapeutics Debt to Assets

Calidi Biotherapeutics Cash Flow

Calidi Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis